Search results
Showing results for
Researchers have made a breakthrough in more precisely targeting drugs to cancers. Using ultrasound and lipid drug carriers (liposomes), a multi-disciplinary team of biomedical engineers, oncologists, radiologists and anaesthetists at the University of Oxford have developed a new way to improve the targeting of cancer drugs to tumours.
ssociation between deep cervical lymph node dissection and dementia incidence in patients with head and neck cancer: a systematic review
Journal article
Omar M. et al, (2026), European Journal of Plastic Surgery, 49
The functional resonance analysis method in healthcare: How knowledge is produced within and across scientific communities
Journal article
Lounsbury O. et al, (2026), Safety Science, 196
Editorial: Post pregnancy contraception
Journal article
Makins A., (2026), Best Practice and Research Clinical Obstetrics and Gynaecology, 105
Validating Primary and Secondary Healthcare Resource Use and Costs estimates in OMOP-Mapped vs Source CPRD-HES Data in the UK
Conference paper
Fabiano G. et al, (2026)
Causes of excess non-lymphoma death in 58,000 patients with DLBCL diagnosed during 1997-2020 and followed for up to 25 years.
Journal article
Challenger A. et al, (2026), Blood Adv
TCR T cells targeting IgA- and IgG-expressing multiple myeloma.
Journal article
Douvlataniotis K. et al, (2026), Blood
Reconsidering the 1 mm rule: Contextualising R1 margin status in rectal cancer.
Journal article
Mason JD. et al, (2026), Colorectal Dis, 28
Vortex-actuated pre-enrichment accelerates human regulatory T cell sorting and improves early fitness
Journal article
Ho QY. et al, (2026), Molecular Therapy Advances, 34, 201667 - 201667
Storage under hypoxia improves the ability of red cells to release oxygen in ex vivo–perfused human kidneys
Journal article
Rabcuka J. et al, (2026), Blood Red Cells & Iron, 2, 100038 - 100038
0594 Drug-testing in patient-derived renal cell carcinoma organoids reveals pathways of vulnerability and resistance
Journal article
Steven M. et al, (2026), European Urology, 89, S1 - S2
The PRAGMATIC pathway - PRostate cancer diAGnosis and MAnagement Triage In Clinical care.
Journal article
Sharma A. et al, (2026), BJU Int
Developing and validating a neonatal screening tool for congenital anomalies to be used in low- and middle-income country settings.
Journal article
Gebreselassie HA. and Lakhoo K., (2026), BMJ Glob Health, 11
Substantial international variation in the cost of blood group and save and crossmatch: A systematic review.
Journal article
Fabiano G. et al, (2026), Br J Haematol
Mast-cell derived nerve growth factor drives ILC2 pro-tumoral functions in bladder cancer.
Journal article
Falquet M. et al, (2026), Nat Commun
Comparative safety, efficacy, and predictors of complete occlusion of flow diverter devices in the treatment of unruptured distal anterior cerebral artery aneurysms.
Journal article
Salim HA. et al, (2026), Neurol Sci, 47
djunctive pharmacological strategies for residual risk reduction after myocardial revascularisation.
Journal article
Oshima A. et al, (2026), EuroIntervention, 22, 202 - 223
Metabolism in Tumour-Induced Bone Disease.
Journal article
Ormsby RT. and Edwards CM., (2026), Curr Osteoporos Rep, 24
ssessing the effects of a 3D pathology tissue-processing workflow on downstream molecular analyses.
Preprint
Baraznenok E. et al, (2026)
High-cholesterol diet fuels myeloma progression, dysregulates adipokine expression in vivo, and impairs treatment response ex vivo.
Journal article
Gámez B. et al, (2026), Haematologica
ctivity outcomes from past patients after total knee arthroplasty: regression tree analysis to generate insights for new patients
Conference paper
PINEDO VILLANUEVA R. et al, (2026)